Latest Stories from Science

Data Presented at the 30th European Association of Urology (EAU) Congress Further Assesses Efficacy, Safety and Tolerability of ZYTIGA® (Abiraterone Acetate) in Both Pre- and Post- Chemotherapy Settings in mCRPC

2015-03-21T02:46:08-07:00

Cerulean Appoints Chris Guiffre President & Chief Executive Officer

2015-03-20T13:41:08-07:00

Paul Friedman to continue to serve as Executive Chairman and Bill Rastetter to continue to serve as Lead Independent Director

3M Makes a Greater Commitment in China's West Region

2015-03-20T10:34:44-07:00

Plans for a New Customer Technical Center Unveiled

Dow Expands Partnership with FIRST® to Promote STEM Education

2015-03-20T07:45:16-07:00

Partnership will promote employee engagement and hands-on learning experiences for students

Merz Dermatology to Present New Pediatric Clinical Data on Naftin® (naftifine HCl) Gel 2% at the 2015 American Academy of Dermatology (AAD) Meeting

2015-03-20T07:03:09-07:00

Syros Pharmaceuticals Announces New Research Published on Role of Cell Signaling Pathways in Gene Control

2015-03-20T06:11:09-07:00

- Paper in Molecular Cell by Syros scientific founders validates approach to therapeutic gene control in cancers with signaling and transcriptional dependencies -

OncoCyte Announces Availability of Abstracts With New Clinical Data From Studies of PanC-Dx™ Cancer Diagnostic in Bladder and Breast Cancer

2015-03-20T05:01:43-07:00

Data to be Presented at American Association for Cancer Research 2015 Annual Meeting

inviCRO Expands Preclinical Histology Service Capabilities with the Opening of inviCRO Seattle

2015-03-20T04:00:09-07:00

inviCRO expands 2D/3D histology imaging and analysis services for research and drug development

Discovery Cube LA Opens New “Science of Hockey” Exhibit in Partnership with the LA Kings

2015-03-19T17:21:15-07:00

The world’s fastest game on ice comes to life in all-new science based exhibit surrounding the Stanley Cup success of the team

Batu Biologics Publishes Preclinical Data for ValloVax™

2015-03-19T17:17:19-07:00

Company authors peer-reviewed publication about lung cancer immune therapy targeting the tumor endothelium

Rice University to Host Fifth Eubank Conference on Real World Markets

2015-03-19T13:43:09-07:00

“A Focus on Energy” jointly-sponsored by Rice University’s Center for Computational Finance and Economic Systems (CoFES) and the Center for Energy Studies (CES) at Rice University’s Baker Institute for Public Policy

Cerulean Reports Fourth Quarter 2014 Corporate Highlights and Financial Results

2015-03-19T13:16:08-07:00

Phase 1b/2 trial of CRLX101 in renal cell carcinoma achieves primary endpoint Closed debt facility for up to $26.0 million with Hercules Technology Growth Capital in first quarter

Cerulean Announces Phase 1b/2 Trial of CRLX101 in Combination with Avastin® in Relapsed Renal Cell Carcinoma Meets Primary Endpoint

2015-03-19T13:14:08-07:00

Preliminary top-line data demonstrate a median PFS of 9.9 months – current standard of care is approximately 3.5 months

Tekla Life Sciences Investors Announce Renewal of Share Repurchase Program

2015-03-19T11:30:08-07:00

Galderma Announces Positive Phase 3 Trial Results of Investigational Adapalene 0.3%/Benzoyl Peroxide 2.5% (0.3% A/BPO) for the Treatment of Acne

2015-03-19T11:13:09-07:00

Pivotal Data to be Presented at This Year’s American Academy of Dermatology Meeting